Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic diversity of Bacteroides fragilis toxins and neutralization with single domain antibody.

Cell chemical biology·2026
Same author

Nanobody-based Pannexin1 channel inhibitors increase survival after cardiac ischemia/reperfusion.

Cell and tissue research·2025
Same author

Small but Mighty: Nanobodies in the Fight Against Infectious Diseases.

Biomolecules·2025
Same author

Evidence for a model of conformational change by the <i>Plasmodium falciparum</i> circumsporozoite protein during sporozoite development in the mosquito host through the use of camelid single-domain antibodies.

Infection and immunity·2025
Same author

Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody.

eLife·2025
Same author

In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting.

Antibodies (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jun 8, 2026

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

Nanobodies®: proficient tools in diagnostics.

Lieven Huang1, Serge Muyldermans, Dirk Saerens

  • 1MRC Clinical Sciences Centre, Imperial College London, London, UK.

Expert Review of Molecular Diagnostics
|September 17, 2010
PubMed
Summary
This summary is machine-generated.

Nanobodies, derived from Camelidae heavy-chain only antibodies, offer unique properties for diagnostics. These small antibody fragments show promise in cancer immunosensors, chromatography, and in vivo imaging applications.

More Related Videos

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Related Experiment Videos

Last Updated: Jun 8, 2026

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Area of Science:

  • Biotechnology
  • Immunology
  • Nanotechnology

Background:

  • Conventional antibodies are being engineered into smaller formats, such as Nanobodies, for improved diagnostic applications.
  • Nanobodies are derived from heavy-chain only antibodies found in Camelidae, possessing unique natural characteristics.
  • Their small size offers significant advantages for developing advanced diagnostic tools.

Purpose of the Study:

  • To highlight the potential of Nanobodies in diagnostic development.
  • To present current applications of Nanobodies in various diagnostic fields.
  • To showcase the functional properties of Nanobodies for diagnostic tools.

Main Methods:

  • Utilizing Nanobodies, which are antigen-binding fragments derived from Camelidae heavy-chain only antibodies.
  • Leveraging the inherent biophysical, biochemical, and pharmacological characteristics of Nanobodies.
  • Applying Nanobodies in diverse diagnostic contexts including immunosensors, immunoaffinity chromatography, and imaging.

Main Results:

  • Nanobodies demonstrate unique biophysical, biochemical, and pharmacological properties.
  • These small antibody fragments are suitable for drug development and diagnostic tools.
  • Successful applications include cancer immunosensors, immunoaffinity chromatography, and in vivo/intracellular imaging.

Conclusions:

  • Nanobodies represent a promising class of molecules for advanced diagnostic applications.
  • Their unique properties and small size facilitate development in areas like cancer diagnostics and imaging.
  • Further development of Nanobodies is expected to enhance diagnostic capabilities.